The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy, safety, tolerability, and PK of the HDAC inhibitor resminostat in sorafenib-refractory hepatocellular carcinoma (HCC): Phase II SHELTER study.
Michael Bitzer
No relevant relationships to disclose
Marius Horger
No relevant relationships to disclose
Tom M Ganten
No relevant relationships to disclose
Ulrich M Lauer
No relevant relationships to disclose
Marcus A Woerns
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Jens T Siveke
No relevant relationships to disclose
Matthias M. Dollinger
No relevant relationships to disclose
Guido Gerken
No relevant relationships to disclose
Henning Wege
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Edoardo G Giannini
Research Funding - 4SC
Other Remuneration - 4SC
Vittorina Zagonel
No relevant relationships to disclose
Umberto Cillo
No relevant relationships to disclose
Franco Trevisani
Consultant or Advisory Role - Bayer
Honoraria - Marben; Sudler & Hennessey
Research Funding - Bayer
Other Remuneration - Bayer
Armando Santoro
No relevant relationships to disclose
Vincenzo Montesarchio
No relevant relationships to disclose
Bernhard Hauns
Employment or Leadership Position - 4SC
Stock Ownership - 4SC
Julia Asche
Employment or Leadership Position - 4SC
Stock Ownership - 4SC
RĂ¼diger Jankowsky
Employment or Leadership Position - 4SC
Anna Mais
Employment or Leadership Position - 4SC
Stock Ownership - 4SC
Bernd Hentsch
Employment or Leadership Position - 4SC
Stock Ownership - 4SC